Science Highlights shares clinical research and translational science insights from the field of transplantation and cellular therapy.
Based on preclinical evidence, researchers believe CD45-directed radioimmunotherapy (RIT) with astatine-211 (211At) may have utility as a conditioning regimen prior to autologous gene therapy.